With many years of experience in radiology, nuclear medicine and bone densitometry in international clinical trials, Banook Group central imaging is a full service Imaging core laboratory specialized in medical imaging standardization, centralization and reading.
Our staff expertise, state-of-the-art technology and detailed procedures can meet any of your imaging needs from study start-up to final report. In line with the FDA guidance emphasizing the need for rigorous imaging protocols in clinical trials, we fulfill 3 major commitments:
Provide a full range of services from turn-key image acquisition and processing to image review and analysis,
Provide standardized, central, independent, blinded, objective expert review of imaging endpoints across all sites, patients and time-points,
Provide state-of-the-art tools for supporting Imaging endpoint assessment (data storage, distribution and analysis).
To ensure imaging analyses of the highest precision and accuracy, Banook Group central imaging assigns your project to radiologists, imaging technicians, and readers dedicated to your clinical trial as well as a network of world renowned radiologists, medical expert and KOL with special expertise in the medical condition under investigation or analytical method.
Our certified team of radiologists has extensive experience with all imaging modalities to give you accurate, comprehensive and timely image analyses for a broad range of imaging modalities (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET, PET/CT), echocardiography, angiography, ultrasound, DEXA, X-Ray).
Banook Group central imaging provides protocol review, charter development, comprehensive project management, data management, site qualification, quality control and image analysis solutions in most therapeutics areas. We have an experienced team in oncology that keeps continuously abreast of the latest scientific, technical and regulatory innovations concerning the following endpoints to ensure their optimal implementation in your project:
RECIST and RECIST 1.1
IrRC (Immune related Response Criteria),
Tumor Growth Rates (TGR),
Volumetric Assessment of lession,
We provide medical, radiological and regulatory expertise through all stages of therapeutic trials and drug development. We assist you with selecting the best response criteria to meet the objectives of your project.
Banook Group offers a full range of comprehensive and proactive Imaging services and technologies solutions including: